Qian Zhan Wang·2025-05-05 01:24Core Insights - Brain-computer interface (BCI) technology enables direct communication between the brain and external devices, revolutionizing human-machine interaction and integrating advanced technologies such as neuroscience, AI, and new materials [2][4] - The global BCI industry is projected to reach $7.63 billion by 2029, indicating significant growth potential [4] - China and the United States are leading in BCI development, with a notable number of companies and products entering clinical stages [6][7] Industry Overview - The BCI industry is characterized by a competitive landscape with active companies in over 40 countries, primarily in the US and China, where the number of companies exceeds 100 [7] - As of early 2024, China holds 55.62% of the global patent technology in BCI, leading all countries [6] - The industry is still in its early stages, with many startups emerging and a significant increase in patent applications and funding events [55] Key Companies - Qiangnao Technology: Founded in 2018, it specializes in non-invasive BCI technology and has over 200 core patents, with a goal to help 1 million disabled individuals regain mobility [10][12] - Brain Tiger Technology: Established in 2021, it focuses on flexible invasive BCI technology and has made significant breakthroughs in core technologies [13][15] - Brain Land Technology: Founded in 2018, it integrates BCI technology with medical big data and AI, holding 147 patents as of April 2025 [20][21] - Borecon: Founded in 2021, it has developed high-performance BCI systems and has over 100 patents [24][25] - Weiling Medical: Established in 2019, it is focused on BCI technology and has initiated clinical research for implantable BCI systems [28] - Roulint Technology: Founded in 2020, it specializes in non-invasive BCI technology for consumer electronics and medical applications, holding 161 patents [33] - Aipeng Medical: Established in 2001, it has invested in BCI technology and developed several non-invasive BCI products [36][37] - Kedou BCI: Founded in 2016, it focuses on invasive BCI technology and has developed various microelectrodes and related devices [40][41] - Sanbo Neuroscience: Established in 2003, it has over 50 patents and is involved in clinical applications of BCI technology for neurological disorders [43] - Chengyitong: Founded in 2011, it has developed several non-invasive BCI prototypes and holds 303 patents, covering key areas of BCI technology [46] Technological Insights - BCI technology is categorized into invasive, semi-invasive, and non-invasive types, with a focus on improving accuracy, feedback speed, and safety [50][52] - The majority of BCI product development is currently centered on non-invasive devices due to their higher safety and market acceptance [53] - As of 2024, there are 222 registered medical devices related to BCI in China, with 194 classified as Class II medical devices [53]